Senescence-associated SIN3B promotes inflammation and pancreatic cancer progression
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is strikingly resistant to conventional therapeutic approaches. We previously demonstrated that the histone deacetylase-associated protein SIN3B is essential for oncogene-induced senescence in cultured cells. Here, using a mouse model of pancreatic cancer, we have demonstrated that SIN3B is required for activated KRAS-induced senescence in vivo. Surprisingly, impaired senescence as the result of genetic inactivation of Sin3B was associated with delayed PDAC progression and correlated with an impaired inflammatory response. In murine and human pancreatic cells and tissues, levels of SIN3B correlated with KRAS-induced production of IL-1α. Furthermore, evaluation of human pancreatic tissue and cancer cells revealed that Sin3B was decreased in control and PDAC samples, compared with samples from patients with pancreatic inflammation. These results indicate that senescence-associated inflammation positively correlates with PDAC progression and suggest that SIN3B has potential as a therapeutic target for inhibiting inflammation-driven tumorigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Compared to other malignancies, pancreatic cancer is highly resistance to chemotherapy and targeted therapy [3, 4].”
From Inhibition of HIF-1α by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma (2015) · cites this paper as [3]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 1×
“Accordingly, senescenceassociated β-gal (SA–β-gal) positivity (44) was markedly reduced in Sin3B-deficient pancreata (Figure 3B).”
Aging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954 · cited 1×
“Through its ability to drive a potent cell-cycle exit, cellular senescence has long been considered a tumor-suppressive mechanism (9, 13, 14).”
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00309-x · Cited by 2,471
A complex secretory program orchestrated by the inflammasome controls paracrine senescence
Acosta, J. C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J. P., Athineos, D., Kang, T.-W., Lasitschka, F., Andrulis, M., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2784 · Cited by 2,278 · cited 1×
“In addition, a recent study indicated that disabling the IL-1R/IL-1α pathway partially prevents oncogene-induced senescence and paracrine senescence (50).”
Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion
Rodier, F., Coppé, J.-P., Patil, C. K., Hoeijmakers, W. A. M., Muñoz, D. P., Raza, S. R., Freund, A., Campeau, E., Davalos, A. R., & Campisi, J. (2009) · Nature Cell Biology · doi:10.1038/ncb1909 · Cited by 2,232
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
Yoshimoto, S., Loo, T. M., Atarashi, K., Kanda, H., Sato, S., Oyadomari, S., Iwakura, Y., Oshima, K., Morita, H., Hattori, M., et al. (2013) · Nature · doi:10.1038/nature12347 · Cited by 2,219 · cited 1×
“In agreement with our observations, a recent study indicated that the senescence secretome promotes liver cancer progression (21).”
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160 · cited 1×
“Senescence is associated with low proliferation in a wide variety of cancer preneoplastic lesions, including lung adenoma, melanocytic naevi, and PanIN (8, 10–12).”
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086 · cited 9×
“However, the molecular factors that link oncogene activation to SASP expression remain largely elusive.”
InfluentialFour faces of cellular senescence
Rodier, F., & Campisi, J. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201009094 · Cited by 2,070 · cited 2×
“IL-1α has recently been shown to serve as an upstream regulator of SASP production (45).”
The essence of senescence: Figure 1.
Kuilman, T., Michaloglou, C., Mooi, W. J., & Peeper, D. S. (2010) · Genes & Development · doi:10.1101/gad.1971610 · Cited by 2,038 · cited 2×
“Through its ability to drive a potent cell-cycle exit, cellular senescence has long been considered a tumor-suppressive mechanism (9, 13, 14).”
Research works printed but not linked: 1
- Acosta JC, et al. A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat Cell Biol. 2013;15(8):978–990. doi: 10.1038/ncb2784. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI · Paper page
Cited by
How the ageing microenvironment influences tumour progression
Fane, M., & Weeraratna, A. T. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0222-9 · Cited by 849
Mazur, P. K., Herner, A., Mello, S. S., Wirth, M., Hausmann, S., Sánchez-Rivera, F. J., Lofgren, S. M., Kuschma, T., Hahn, S. A., Vangala, D., et al. (2015) · Nature Medicine · doi:10.1038/nm.3952 · Cited by 397
Senescence-associated inflammatory responses: aging and cancer perspectives
Lasry, A., & Ben-Neriah, Y. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.02.009 · Cited by 408
NAD+ metabolism governs the proinflammatory senescence-associated secretome
Nacarelli, T., Lau, L., Fukumoto, T., Zundell, J., Fatkhutdinov, N., Wu, S., Aird, K. M., Iwasaki, O., Kossenkov, A. V., Schultz, D., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0287-4 · Cited by 402
Self-citationTh17 Cells in Cancer: The Ultimate Identity Crisis
Bailey, S. R., Nelson, M. H., Himes, R. A., Li, Z., Mehrotra, S., & Paulos, C. M. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00276 · Cited by 334
“Th17 CELL-MEDIATED INFLAMMATION IN CANCER Inflammation has long been recognized as a mediator of tumor progression in diseases such as colorectal (80), pancreatic (81, 82), and lung (83) cancer.”
BackgroundTakahashi, A., Loo, T. M., Okada, R., Kamachi, F., Watanabe, Y., Wakita, M., Watanabe, S., Kawamoto, S., Miyata, K., Barber, G. N., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03555-8 · Cited by 350
Cellular senescence and SASP in tumor progression and therapeutic opportunities
Dong, Z., Luo, Y., Yuan, Z., Tian, Y., Jin, T., & Xu, F. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02096-7 · Cited by 259
“For example, genetic knockout of Sin3B in the mouse genome inhibits pancreatic cancer progression by preventing CS induced by KRAS and reducing IL-1α in the SASP [149].”
BackgroundFunctions of Immune Checkpoint Molecules Beyond Immune Evasion
Zhang, Y., & Zheng, J. (2020) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-15-3266-5_9 · Cited by 260
Senescent cells: SASPected drivers of age-related pathologies
Ovadya, Y., & Krizhanovsky, V. (2014) · Biogerontology · doi:10.1007/s10522-014-9529-9 · Cited by 232
Cancer metabolism in space and time: Beyond the Warburg effect
Danhier, P., Bański, P., Payen, V. L., Grasso, D., Ippolito, L., Sonveaux, P., & Porporato, P. E. (2017) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2017.02.001 · Cited by 214
Trovato, R., Fiore, A., Sartori, S., Canè, S., Giugno, R., Cascione, L., Paiella, S., Salvia, R., De Sanctis, F., Poffe, O., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0734-6 · Cited by 189
“The presence of the highest degree of desmoplasia among all solid tumors and the occurrence of a chronic inflammation endorse a critical role for tumor microenvironment on pancreatic carcinogenesis [4, 5].”
BackgroundLow-Grade Chronic Inflammation: a Shared Mechanism for Chronic Diseases
Cifuentes, M., Verdejo, H., Castro, P., Corvalán, A. H., Ferreccio, C., Quest, A. F. G., Kogan, M. J., & Lavandero, S. (2024) · Physiology · doi:10.1152/physiol.00021.2024 · Cited by 203
Zhao, T., Ren, H., Jia, L., Chen, J., Xin, W., Yan, F., Li, J., Wang, X., Gao, S., Qian, D., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.2948 · Cited by 142
“Compared to other malignancies, pancreatic cancer is highly resistance to chemotherapy and targeted therapy [3, 4].”
BackgroundKoltai, T., Reshkin, S. J., Carvalho, T. M. A., Molfetta, D. D., Greco, M. R., Alfarouk, K. O., & Cardone, R. A. (2022) · Cancers · doi:10.3390/cancers14102486 · Cited by 132
Lau, L., Porciuncula, A., Yu, A., Iwakura, Y., & David, G. (2019) · Molecular and Cellular Biology · doi:10.1128/mcb.00586-18 · Cited by 119
“Of note, previous studies that have aimed at deciphering the contribution of the SASP in tumorigenesis have relied on models where all aspects of senescence are abrogated (28, 29).”
BackgroundMethodInfluentialSelf-citationCellular senescence in gastrointestinal diseases: from pathogenesis to therapeutics
Frey, N., Venturelli, S., Zender, L., & Bitzer, M. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.146 · Cited by 97
Cancer secretome and inflammation: The bright and the dark sides of NF-κB
Capece, D., Verzella, D., Tessitore, A., Alesse, E., Capalbo, C., & Zazzeroni, F. (2018) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2017.08.004 · Cited by 90
Cellular senescence in cancer: clinical detection and prognostic implications
Domen, A., Deben, C., Verswyvel, J., Flieswasser, T., Prenen, H., Peeters, M., Lardon, F., & Wouters, A. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02555-3 · Cited by 94
“, pancreatitis and pancreatic intraepithelial neoplasias), a senescenceassociated inflammatory SASP was linked to PDAC progression [189].”
BackgroundElyahu, Y., & Monsonego, A. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101231 · Cited by 103
“demonstrated in various types of tumors, both in human and in mice (Golomb et al., 2015; Loaiza and Demaria, 2016; Rielland et al., 2014; Wang and DuBois, 2015; Zinger et al., 2017).”
Non-Cell-Autonomous Regulation of Cellular Senescence in Cancer
Mitri, D. D., & Alimonti, A. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.10.005 · Cited by 100
Pro- and anti-tumorigenic functions of the senescence-associated secretory phenotype
Lau, L., & David, G. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1565658 · Cited by 70
“Indeed, our group has demonstrated using mouse models that disabling senescence delays tumorigenesis in the pancreas, but enhances tumor progression in the prostate [77,91].”
BackgroundSelf-citationVastrad, B. M., Vastrad, C. M., Godavarthi, A., & Hariharapura, R. C. (2017) · Medical Oncology · doi:10.1007/s12032-017-1043-x · Cited by 77
Emerging Roles of Epigenetic Regulator Sin3 in Cancer
Bansal, N., David, G., Farias, E., & Waxman, S. (2016) · Advances in cancer research · doi:10.1016/bs.acr.2016.01.006 · Cited by 62
“Given the well-established contribution of inflammation in pancreatic cancer progression (Ling et al., 2012), it is tempting to speculate that Sin3B promotes PDAC progression by triggering senescence-associated inflammation in KRas-expressing pancreatic lesions.”
BackgroundInfluentialSelf-citationIntegrative Modeling of a Sin3/HDAC Complex Sub-structure
Banks, C. A. S., Zhang, Y., Miah, S., Hao, Y., Adams, M. K., Wen, Z., Thornton, J. L., Florens, L. A., & Washburn, M. P. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.03.080 · Cited by 50
“…the complex assembles, is frequently mutated in human cancers (Kandoth et al., 2013), and Sin3 complexes offer likely therapeutic targets for a variety of diseases (Kandoth et al., 2013), including triple-negative breast cancer (Kwon et al., 2015) and pancreatic cancer (Rielland et al., 2014).”
Oncogenic senescence: a multi-functional perspective
Baker, D. J., Alimirah, F., van Deursen, J. M., Campisi, J., & Hildesheim, J. (2017) · Oncotarget · doi:10.18632/oncotarget.15742 · Cited by 45
“On the other hand – and in stark contrast – pancreasspecific (and senescence deficient) KRASG12DSin3B-/- mice have appreciably delayed conversions of pancreatic intraepithelial neoplasia to ductal carcinoma (PDAC) and PDAC-associated death [30].”
SIN3A and SIN3B differentially regulate breast cancer metastasis
LEWIS, M. J., Liu, J., Libby, E. F., Lee, M., Crawford, N. P. S., & Hurst, D. R. (2016) · Oncotarget · doi:10.18632/oncotarget.12805 · Cited by 50
“In pancreatic cancer, Sin3B was found to promote cancer progression by senescence-associated inflammation [21].”
Gemcitabine induces cell senescence in human pancreatic cancer cell lines
Song, Y. H., Baba, T., & Mukaida, N. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.06.063 · Cited by 49
“SASP, a typical feature of cell senescence, is characterized by enhanced expression of IL-6 and/or CXCL8 and its related chemokines in senescent cells [15, 16].”
InfluentialCircumventing senescence is associated with stem cell properties and metformin sensitivity
Deschênes‐Simard, X., Parisotto, M., Rowell, M., Le Calvé, B., Igelmann, S., Moineau‐Vallée, K., Saint‐Germain, E., Kalegari, P., Bourdeau, V., Kottakis, F., et al. (2019) · Aging Cell · doi:10.1111/acel.12889 · Cited by 45
“We thus compared the transcriptome and biological properties of Information Figure S1a), DNA damage foci (Figure 1i), and increased staining for the heterochromatin marker HP1 ‐ γ (Rielland et al., 2014; Figure 1j).”
ResultNormal Aging and Its Role in Cancer Metastasis
Fane, M. E., & Weeraratna, A. T. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a037341 · Cited by 45
“…(PDAC)mousemodel protected animals from metastatic progression via a reduction in fibroblast SASP activation and reduced IL1-α secretion (Rielland et al. 2014) and uncoupling of this pathway within this PDAC model via IL1-α genetic ablation further inhibited metastatic growth (Lau et…”
BackgroundZhao, Y., Wu, Z., Chanal, M., Guillaumond, F., Goehrig, D., Bachy, S., Principe, M., Ziverec, A., Flaman, J., Collin, G., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-3763 · Cited by 40
Implication of epigenetics in pancreas development and disease
Quilichini, E., & Haumaître, C. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.10.010 · Cited by 39
Bainor, A. J., Saini, S., Calderon, A., Casado-Polanco, R., Giner-Ramirez, B., Moncada, C., Cantor, D. J., Ernlund, A. W., Litovchick, L., & David, G. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.11.024 · Cited by 35
“Interestingly, Sin3b-deleted cells are refractory to oncogene-induced senescence and, in some settings, exhibit altered terminal differentiation (Cantor andDavid, 2017; Dannenberg et al., 2005; David et al., 2008; Grandinetti et al., 2009; Rielland et al., 2014).”
Self-citationThe role of host environment in cancer evolution
Solary, É., & Laplane, L. (2020) · Evolutionary Applications · doi:10.1111/eva.13039 · Cited by 33
“…deletion of the senescence-inducing factor SIN3B (a histone deacetylase-associated protein) in a KrasG12Ddriven mouse model of pancreatic intraepithelial neoplasia significantly reduces the initiation and progression of the pancreatic lesions by decreasing IL-1β secretion (Rielland et al., 2014).”
BackgroundTherapy-induced microenvironmental changes in cancer
Ma, Y., Yang, H., Pitt, J. M., Kroemer, G., & Zitvogel, L. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1401-8 · Cited by 35
“However, persistent secretion of SASP components, including matrix metalloproteinase, IL-1α, and IL6, may contribute to inflammation-driven tumorigenesis [29–32].”
BackgroundNapoletani, G., Protto, V., Marcocci, M. E., Nencioni, L., Palamara, A. T., & Chiara, G. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126279 · Cited by 28
“showed that HDAC1 increased in human postmortem brains in an age-dependent manner, and Sin3 has also been associated with senescence [32,56].”
BackgroundCdk9 and H2Bub1 signal to Clr6-CII/Rpd3S to suppress aberrant antisense transcription
Sansó, M., Parua, P. K., Pinto, D., Svensson, J. P., Pagé, V., Bitton, D. A., MacKinnon, S., Garcia, P. S., Hidalgo, E., Bähler, J., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa474 · Cited by 26
“The mammalian ortholog of Rpd3S/Clr6-CII is the Sin3B complex, which localizes to transcribed genes and is a potential therapeutic target in pancreatic cancer (30,64).”
BackgroundArrested development and the great escape – The role of cellular senescence in pancreatic cancer
Moir, J. A. G., White, S. A., & Mann, J. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.10.018 · Cited by 28
Duvillié, B., Kourdoughli, R., Druillennec, S., Eychène, A., & Pouponnot, C. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.563267 · Cited by 26
“September 2020 | Volume 11 | Article 563267 inducing factor SIN3B reduced the initiation and progression of pancreatic lesions, while decreasing secretion of the SASP factor IL-1a (22).”
BackgroundInfluentialStructure of a SIN3–HDAC complex from budding yeast
Guo, Z., Chu, C., Lu, Y., Zhang, X., Xiao, Y., Wu, M., Gao, S., Wong, C. C. L., Zhan, X., & Wang, C. (2023) · Nature Structural & Molecular Biology · doi:10.1038/s41594-023-00975-z · Cited by 25
DiMauro, T., Cantor, D. J., Bainor, A. J., & David, G. (2014) · Oncogene · doi:10.1038/onc.2014.322 · Cited by 20
Self-citationCannon, A. C., Thompson, C. M., Maurer, H. C., Atri, P., Bhatia, R., West, S. C., Ghersi, D., Olive, K. P., Sushil Kumar, K., & Batra, S. K. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-1359 · Cited by 19
“These pathways provide a survival advantage by preventing cancer cell apoptosis and senescence (4, 5), and increasing epithelial-to-mesenchymal transition (6).”
BackgroundThe Dual Role of Senescence in Pancreatic Ductal Adenocarcinoma
Porciuncula, A., Hajdu, C. H., & David, G. (2016) · Advances in cancer research · doi:10.1016/bs.acr.2016.05.006 · Cited by 20
Self-citationK128 ubiquitination constrains RAS activity by expanding its binding interface with GAP proteins
Magits, W., Steklov, M. Y., Jang, H., Sewduth, R. N., Florentin, A., Lechat, B., Sheryazdanova, A., Zhang, M., Šimíček, M., Prag, G., et al. (2024) · The EMBO Journal · doi:10.1038/s44318-024-00146-w · Cited by 19
“This pro-tumorigenic SASP phenotype is commonly observed during PDAC progression (Rielland et al, 2014).”
The microbiota and aging microenvironment in pancreatic cancer: Cell origin and fate
Chen, Z., Wang, Z., Du, Y., Shi, H., & Zhou, W. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188826 · Cited by 17
SIN3B promotes integrin αV subunit gene transcription and cell migration of hepatocellular carcinoma
Cai, Q., Liu, Y., Zhu, P., Kang, C. L., Xu, H., Qi, B., Wang, R., Dong, Y., & Wu, X. (2018) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjy050 · Cited by 17
Anti-inflammatory properties of bergenin in mice
Oliveira, G., Araujo, A. K. S., Pacheco, G., Oliveira, A., de Carvalho, J. L., Chaves, L. S., Sousa, G. C., Lopes, A., da Silva, P. F., Carolina, A., et al. (2019) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2019.90709 · Cited by 17
“When the body is unable to control inflammation adequately, a chronic inflammatory disease is triggered (Daham et al., 2014; Herenius et al., 2013; Rielland et al., 2014; Singh et al., 2013; Taams, 2018; Zygmunt et al., 2014).”
BackgroundSoft repression: Subtle transcriptional regulation with global impact
Mitra, A., Raicu, A., Hickey, S. L., Pile, L. A., & Arnosti, D. N. (2020) · BioEssays · doi:10.1002/bies.202000231 · Cited by 15
SIN3B Loss Heats up Cold Tumor Microenvironment to Boost Immunotherapy in Pancreatic Cancer
Zhang, Z., Tang, Y., Wang, Y., Xu, J., Yang, X., Liu, M., Mazzone, M., Niu, N., Sun, Y., Tang, Y., et al. (2024) · Advanced Science · doi:10.1002/advs.202402244 · Cited by 15
Chromatin-Associated Protein SIN3B Prevents Prostate Cancer Progression by Inducing Senescence
Bainor, A. J., Deng, F., Wang, Y., Lee, P., Cantor, D. J., Logan, S. K., & David, G. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3410 · Cited by 14
“We have previously demonstrated that SIN3B is required for cellular senescence upon exposure to stress (12,16).”
BackgroundResultSelf-citationGraveline, R., Marcinkiewicz, K. M., Choi, S., Paquet, M., Wurst, W., Floß, T., & David, G. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00522-16 · Cited by 16
Self-citationShen, J., Gao, H., Li, B., Huang, Y., & Shi, Y. (2023) · Aging · doi:10.18632/aging.204876 · Cited by 13
“Additionally, research has found that the aging-related SIN3B can promote inflammation and pancreatic cancer progression [18].”
BackgroundNavigating the paradox of senescence and chemoresistance in pancreatic cancer
Jeiroshi, A., Deng, J., Xu, Z., Comandatore, A., Xu, G., Glaviano, A., Morelli, L., Garajová, I., & Giovannetti, E. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.06.007 · Cited by 11
Inflammation-Related Pancreatic Carcinogenesis: Mechanisms and Clinical Potentials in Advances
Dai, J., Jiang, M., Wang, X., & Tian, L. (2017) · Pancreas · doi:10.1097/mpa.0000000000000886 · Cited by 11
“Deletion of Sin3b decreased Il1a expression and delayed progression of Kras-driven pancreatic lesions.(61) An intact CD4 T-cell–mediated adaptive immune responsewas identified to execute the clearance of senescent cells.”
BackgroundZebrafish sin3b mutants are viable but have size, skeletal, and locomotor defects
Moravec, C. E., Yousef, H., Kinney, B. A., Salerno‐Eichenholz, R., Monestime, C. M., Martin, B. L., & Sirotkin, H. I. (2017) · Developmental Dynamics · doi:10.1002/dvdy.24581 · Cited by 14
“Furthermore, Sin3b dependent control of senescence has also been shown in an oncogene driven pancreatic cancer model (Rielland et al., 2014).”
BackgroundThe potential of targeting Sin3B and its associated complexes for cancer therapy
Cantor, D. J., & David, G. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1386655 · Cited by 11
“vents PDAC progression and inhibits the growth and invasion potential of cancer cells [40,76,88,90].”
BackgroundSelf-citationAdipocytes and Neutrophils Give a Helping Hand to Pancreatic Cancers
Bronte, V., & Tortora, G. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0682 · Cited by 7
SIN3B, the SASP, and pancreatic cancer
Cantor, D. J., & David, G. (2014) · Molecular & Cellular Oncology · doi:10.4161/23723548.2014.969167 · Cited by 8
“Surprisingly, we observed the opposite phenomenon: Sin3B-deleted animals exhibited delayed PanIN and PDAC progression and displayed increased survival compared to their wild-type counterparts.(5) We initially asked whether this unexpected observation was due to a requirement for Sin3B in acinar-to-ductal metaplasia (A…”
BackgroundSelf-citationRETRACTED: GATA4 Regulates Inflammation-Driven Pancreatic Ductal Adenocarcinoma Progression
Jiang, W., Chen, C., Huang, L., Shen, J., & Yang, L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.640391 · Cited by 6
“Senescence-associated inflammation induced by KRAS and the histone deacetylase-associated protein SIN3B has been found to positively correlate with PDAC progression (Rielland et al., 2014).”
BackgroundRetractedNAD+: a metabolic knob fine-tuning inflammation during senescence
Søgaard, P. P., & Gil, J. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0047-6 · Cited by 4
Morales-Valencia, J., Petit, C., Calderon, A., Saini, S., & David, G. (2023) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-22-0466 · Cited by 4
Self-citationCalderon, A., Mestvirishvili, T., Boccalatte, F. E., Ruggles, K. V., & David, G. (2024) · Epigenetics & Chromatin · doi:10.1186/s13072-024-00526-w · Cited by 3
“We have shown that Sin3B is a key contributor to cell cycle exit in numerous biological contexts [26–28], with a portion of Sin3B’s pro-quiescence function being mediated in part through its interaction with the Dimerization Partner (DP), Retinoblastoma (RB)-like, E2F, and MuvB (DREAM) complex, a…”
BackgroundSelf-citationTumor Promoting Aspects of Senescence in Cancer Progression
Yang, Q., Xie, Y., & Miao, L. (2016) · Cancer Investigation · doi:10.1080/07357907.2016.1227443 · Cited by 4
“For example, histone deacetylase-associated protein, SIN3B, associates with senescence but positively correlates with inflammatory response in pancreatic ductal adenocarcinoma (6).”
BackgroundPremalignant lesions and cellular senescence
Georgakopoulou, E. A., Evangelou, K., & Gorgoulis, V. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822514-1.00001-8 · Cited by 4
Zhao, T., Ren, H., Jia, L., Chen, J., Xin, W., Yan, F., Li, J., Wang, X., Gao, S., Qian, D., et al. (2019) · Oncotarget · doi:10.18632/oncotarget.27205 · Cited by 3
Chromatin context-dependent deacetylation by the asymmetric Rpd3L
Zhao, H., Li, H., Wang, C., Yang, X., Li, H., Zou, B., Dong, S., Zhang, N., Zhou, Y., Yi, L., et al. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag443 · Cited by 1
“Among these, Sin3 HDACs form conserved multi-subunit complexes from yeast to human [ 6 –9 ], functioning in transcriptional repression [ 10 –13 ] and contributing to key cellular processes such as differentiation and development [ 14 –16 ].”
Sansó, M., Pinto, D., Svensson, J. P., Pagé, V., Parua, P. K., Bitton, D. A., Mbogning, J., Garcia, P., Hidalgo, E., Robert, F., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/240135 · Cited by 1
“An emergent question is whether the Sin3B HDAC complex, the mammalian ortholog of Rpd3S and a potential therapeutic target in pancreatic cancer, is similarly responsive to Cdk9 or H2Bub1 (48,49).”
BackgroundOncogenic KRAS and the Inflammatory Micro-Environment in Pancreatic Cancer
Chang, H.-H., Schmidt, A., & Eibl, G. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803505-4.00005-9
Quilichini, E. (2017) · theses.fr (ABES) · doi:10.70675/5c2d9beaz74c5z4a71z80b0zabce84fcefbc
Li, F., Liu, K., Zhao, Q., Chen, J., Liu, L., Xie, Q.-M., & Yang, J. (2019) · Cancer Research Journal · doi:10.11648/j.crj.20190703.16
“Moreover, activation of inflammatory pathways can promote cell migration, vascular infiltration and angiogenesis, further accelerate cancer progression [26, 27].”
BackgroundChen, Z., Lin, H., Hu, K., Su, R., Lai, N., Yang, Z., & Kang, S. (2018) · Europe PMC (PubMed Central) · doi:10.3969/j.issn.1673-4254.2018.01.04
Application of CRISPR-Cas9 to interrogate novel gene functions in cutaneous melanoma
Matsuyama, L. S. A. S. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.9.2021.tde-23022022-155211
Zhao, Y., Wu, Z., Chanal, M., Guillaumond, F., Goehrig, D., Bachy, S., Principe, M., Ziverec, A., Flaman, J., Collin, G., et al. (2023) · doi:10.1158/0008-5472.c.6511539.v1
Knockout of SIN3B modulates transcriptional programs and cell survival in cutaneous melanoma
Matsuyama, L. S. A. S., Harle, V. J., Offord, V., Droop, A., Rabbie, R., Garg, M., Vázquez‐Cruz, M. E., Robles‐Espinoza, C. D., Turner, G., Fraser, D., et al. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107785
Chen, W., Ju, X., & Chao, B. (2025) · Discover Oncology · doi:10.1007/s12672-025-04186-4
“Moreover, CRP may facilitate tumor progression by inactivating tumor suppressor genes, thereby inhibiting apoptosis, and by modulating signaling pathways that promote tumor cell proliferation, migration, and angiogenesis [16, 17].”
The role of HDAC complexes in cell-cycle gene repression
Barrett, A. K. (2023) · eScholarship (California Digital Library)
Rôle de FAT10 dans la sénescence des hépatocytes et le développement de la NASH
Bernard, L. (2023) · theses.fr (ABES) · doi:10.70675/793b0b93z9794z42d4zb8dfz5f3d68268a9b
Kroehling, L., Spinella, A., Varelas, X., & Monti, S. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.30.762827
Metadata
- Authors
- Rielland, M., Cantor, D. J., Graveline, R., Hajdu, C., Mara, L., de Diego Diaz, B., Miller, G., & David, G.
- Affiliations
- New York University (US)
- Corresponding author
- David, Gregory
- Venue
- Journal of Clinical Investigation
- Published
- 2014-04-01
- Volume
- 124
- Issue
- 5
- Pages
- 2125-2135
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC4001548
- OpenAlex
- W2012774586
- Cited by
- 76
- References
- 57
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 5 · 2023: 6 · 2022: 4 · 2021: 5 · 2020: 9 · 2019: 10 · 2018: 4 · 2017: 10 · 2016: 9 · 2015: 4 · 2014: 6
- FWCI
- 6.45
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Cancer Society
- Samuel Waxman Cancer Research Foundation
- NYU Langone Medical Center
- Irma T. Hirschl Trust
- York University
- National Institutes of Health
- School of Medicine, New York University
- National Cancer Institute (T32CA009161, R21CA155736, R01CA148639, P30CA016087)
- National Institute of General Medical Sciences (T32GM007308)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Keywords
- SIN3B, pancreatic ductal adenocarcinoma, oncogene-induced senescence, KRAS, inflammation, IL-1α, histone deacetylase, tumor progression, pancreatitis, therapeutic target
- MeSH terms
- Animals, Humans, Inflammation, Pancreatic Neoplasms, Proto-Oncogene Proteins, Repressor Proteins, Proto-Oncogene Proteins p21(ras), Cellular Senescence, Mice, Knockout, ras Proteins, Carcinoma, Pancreatic Ductal, Cell Line, Tumor, Mice, Interleukin-1alpha
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.